Arlington Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-23
| Closed | -$1.72K | – | 282 |
|
2023
Q3 | $1.72K | Hold |
23
| – | – | ﹤0.01% | 280 |
|
2023
Q2 | $1.77K | Sell |
23
-445
| -95% | -$34.3K | ﹤0.01% | 541 |
|
2023
Q1 | $38.8K | Buy |
+468
| New | +$38.8K | 0.01% | 278 |
|
2022
Q3 | – | Sell |
-1,199
| Closed | -$74K | – | 401 |
|
2022
Q2 | $74K | Buy |
1,199
+455
| +61% | +$28.1K | 0.02% | 202 |
|
2022
Q1 | $44K | Hold |
744
| – | – | 0.01% | 259 |
|
2021
Q4 | $54K | Sell |
744
-1,826
| -71% | -$133K | 0.01% | 272 |
|
2021
Q3 | $180K | Buy |
+2,570
| New | +$180K | 0.05% | 115 |
|
2019
Q2 | – | Sell |
-117
| Closed | -$8K | – | 235 |
|
2019
Q1 | $8K | Buy |
+117
| New | +$8K | 0.01% | 182 |
|